Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Avalo Therapeutics granted an inducement option award for 34,000 shares to a new employee. The award was approved by the Compensation Committee under Nasdaq Listing Rule 5635(c)(4) and priced at $16.60 per share, equal to the closing price on the grant date.
Key figures
- Exercise price
- 16.6
- Shares granted
- 34000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.